ArticleCureus2026
A Two-Decade Journey of Buschke-Löwenstein Tumor Without Malignant Transformation: Clinical Insights and Management.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Buschke-Löwenstein tumor (BLT), also known as giant condyloma acuminatum (GCA), represents a rare, slow-growing pseudoepitheliomatous lesion attributed to human papillomavirus (HPV) infection, characterized by local aggressiveness and potential for malignant transformation. We report a 62-year-old male with a 20-year history of progressive perineal lesions, alongside a medical background of non-muscle-invasive bladder carcinoma and chronic tobacco use. Clinical examination revealed a painless exophytic mass encompassing the perineum, scrotum, and adjacent structures; preoperative imaging and sexually transmitted infection screening yielded unremarkable findings. Histopathological analysis following wide surgical excision confirmed BLT without histological evidence of malignant transformation, with no recurrence observed at 18-month follow-up. Although an uncommon sexually transmitted entity with substantial risks of recurrence and malignant degeneration, BLT diagnosis rests upon integrated clinical and pathological correlation. Complete surgical excision remains the therapeutic cornerstone, potentially supplemented by adjunctive modalities. This case underscores the association with bladder neoplasia, likely mediated by shared risk factors including chronic inflammation and smoking, while emphasizing that early recognition and aggressive resection-even in extensive disease-can yield excellent long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.